FDA Drug recall D-0917-2017
Human Chorionic Gonadotropin, 125 IU HCG, in 0.5 ml syringe, subcutaneous administration, Rx only, Complete Pharmacy & Medical Solutions, M…
- FDA Drug
- Class I
- ongoing
- Published 2017-06-21
On 2017-06-21 the FDA classified a Class I recall of Human Chorionic Gonadotropin, 125 IU HCG, in 0.5 ml syringe, subcutaneous administration, Rx only, Complete Pharmacy & Medical Solutions, M… by Complete Pharmacy And Medical Solutions, citing non-sterility: presence of mold confirmed by outside laboratory at the 14 day culture.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0917-2017 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2015-12-29 |
| Published | 2017-06-21 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Complete Pharmacy And Medical Solutions |
| Distribution | FL |
Product
Human Chorionic Gonadotropin, 125 IU HCG, in 0.5 ml syringe, subcutaneous administration, Rx only, Complete Pharmacy & Medical Solutions, Miami Lakes, FL 33014
Reason
Non-sterility: presence of mold confirmed by outside laboratory at the 14 day culture.
Identifiers
| code_info | Lot # 2079ps5, Exp 02/01/2016 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0917-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.